Enorama Pharma AB (publ) (STO:ERMA)

Market Cap	57.13M -72.6%
Revenue (ttm)	1.45M -87.2%
Net Income	-59.68M
EPS	-0.83
Shares Out	74.59M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	20,086
Open	0.7640
Previous Close	0.7900
Day's Range	0.7640 - 0.8120
52-Week Range	0.2110 - 2.8600
Beta	1.76
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 20, 2026

About Enorama Pharma AB

Enorama Pharma AB (publ), a pharmaceutical company, develops, manufactures, and sells tobacco-free white snus in Sweden. It offers its products under the NIC-S brand name. The company was incorporated in 2006 and is based in Stockholm, Sweden.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2006
• Employees: 4
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: ERMA

Financial Performance

In 2025, Enorama Pharma AB's revenue was 2.74 million, a decrease of -82.63% compared to the previous year's 15.77 million. Losses were -75.14 million, 71.5% more than in 2024.

Data Sources: S&P Global Market Intelligence and QUODD

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by QUODD.

Last checked:

Nov 4, 2026

Data Sources Report a data error